🇺🇸 Antithrombotic Agent in United States
11 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 11
Most-reported reactions
- Pneumonia — 2 reports (18.18%)
- C-Reactive Protein Increased — 1 report (9.09%)
- Febrile Neutropenia — 1 report (9.09%)
- Granuloma — 1 report (9.09%)
- Pleurisy — 1 report (9.09%)
- Pleuritic Pain — 1 report (9.09%)
- Pyrexia — 1 report (9.09%)
- Sepsis — 1 report (9.09%)
- Skin Exfoliation — 1 report (9.09%)
- Wound Infection — 1 report (9.09%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Antithrombotic Agent approved in United States?
Antithrombotic Agent does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Antithrombotic Agent in United States?
Oslo University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.